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Inflammatory bowel diseases are chronic conditions that 
affect large population and the drugs used for their 
treatment have great potential for manifesting adverse 
effects. Regular administration of probiotics incorporated in 
pharmaceutical and/or functional food products may 
significantly prolong, delay or diminish occurrence of these 
diseases or serve as supplements to conventional drugs. The 
probiotic L. casei has proved its beneficial effects in 
improving acquired immunity, decreasing colon 
inflammation, serum cholesterol and increased blood 
pressure, improving lactose tolerance, controlling irritable 
bowel syndrome and decreasing risk of colon cancer 
(Rokka and Rantamaki, 2010). However, as other 
probiotics, it is easily degraded during production and 
storage of the final products and, when orally administered, 
in the aggressive conditions of the GIT. For these reasons, 
microparticles composed of a probiotic carrier Ca-alginate 
and coating of whey protein were prepared, where the 
advantages of the emulsion technique were used to obtain 
particles with smaller size and high probiotic vability 
during processing, storage and GI transit and optimal 
charge for effective colonization in the lower parts of the 
GIT, especially in inflammatory conditions (Smilkov et al., 
2013). The aim of this study was to evaluate the anti-
inflammatory properties of L. casei loaded in whey protein-
alginate microparticles after oral administration to rats in 




Lactobacillus casei-01, freeze-dried probiotic culture was 
purchased from Chr. Hansen, Denmark. It was activated in 
MRS broth (Merck KGaA, Darmstadt, Germany) at 37oC, 
24 h, under aerobic conditions, and the cells were harvested 
by centrifugation at 1500 g for 10 min and washed twice 
with sterile 0.1% w/v peptone water (Merck KGaA, 
Darmstadt, Germany). Alginate (Protanal LF 10/60 LS, fG 
35%-45%, IMCD, FMC Biopolymers, Philpadelphia, PA), 
Tween 80 (Merck KGaA, Darmstadt, Germany) and whey 
protein isolate (ISO 100, Dynamatize Nutrition, Farmers 
Branch, TX) were used for preparation of the 
microparticles. 
 
Preparation and characterization of microparticles 
Emulsion technique was applied to aqueous dispersion of 
alginate and L. casei (10 ml) in olive oil (40 ml) containing 0.2% 
Tween 80 to obtain spherical particles, which were subsequently 
cross-linked in CaCl2 solution and coated with whey protein 
isolate for 1h, isolated, washed and freeze-dried (-50oC, 0.07 
mbar, 24h, Freeze-Dryer, Labconco, USA). Experimental 
design was employed to obtain optimal formulation using 
polynomial regression model at 2nd level with three 
independent variables: concentrations of alginate, whey 
protein and CaCl2. Optimal formulation was prepared of 
2.5% w/w alginate, 3% w/w whey protein and 3% w/w 
CaCl2 solutions. Negatively charged, spherical micro-
particles were obtained with d50 8.65±1,02μm (Mastersizer 
Hydro 2000G, Malvern Instruments Ltd., UK), zeta 
potential -28,04mV (Zetasizer Nano ZS, Malvern 
Instruments Ltd., UK), Ca-content 3.76% (AES-ICP, 
Varian, CA) and high probiotic viability, 10.55±0.21 
log10cfu/g after preparation of the microparticles, and 
8.68±0.15 log10cfu/g in simulated in vivo GI conditions (3 
h, pH 1.5, 0.08 mmol/L HCl, 0.2% w/v pepsin; 3 h, pH 6.8, 
0.05 mmol/L KH2PO4, 1% w/v bile salts, 1% w/v 
pancreatin; 18 h, pH 7.4, 0.1 mol/L, KH2PO4) (Smilkov et 
al., 2013). 
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Parameter  Group of rats 
Negative control  Positive control Non-encapsulated  
L. casei 
Encapsulated L. casei 
Colon weight/ 
total weight (mg/mg) 
0.0067±0.0006 0.0076±0.0014 0.0072±0.0004 0.0070±0.0005 
Activity of MPO (U/g) 8.23±3.32 48.43±8.68 38.97±6.73 18.15±5.10 
Total damage score 0 2.6 2.0 1.8 
Table 1. Anti-inflammatory effect of microencapsulated L. casei 
 
Induction of colonic inflammation, experimental 
design and dosing 
To two groups of Wistar rats (n=6/group, 200-260 g, 12-
15 weeks) in which TNBS colitis was induced, 
suspension of free and encapsulated probiotic (optimal 
formulation), respectively, was administered orally, once 
daily in amount of 8.7 log10cfu/g vehicle. To the third 
group, vehicle only was administered (0.25ml milk, 
positive control), while the forth group of rats (negative 
control) was treated with 0.25ml PBS, pH 6.8. The colitis 
was induced in the first three groups after 2 weeks of 
probiotic and vehicle treatment, which continued for the 
next 6 days. After 24 hours starvation, in anaesthetized 
rats, 0.25ml TNBS in 50% ethanol (10 mg/kg) were 
administered rectally, 8 cm proximally from the anus. 
Rats were sacrificed after 6 days and the anti-
inflammatory effect was evaluated in respect to the 
clinical activity/total damage score (quantified by loss on 
weight, consistency of faeces and rectal bleeding), 
macroscopic and pathohistological changes, colon weight/ 
body weight ratio and mieloperoxidase (MPO) activity 
(Peran et al., 2007). 
RESULTS AND DISCUSSION 
TNBS model appeared to show high correlation between 
the pathohistological, immunological and clinical features 
of the inflammation in IBDs. Comparing to the positive 
control, the total damage score and colon weight/body 
weight ratio decreased when L. casei was administered, 
with non-significant difference when free and 
encapsulated cells were administered (23% and 31% for 
the total damage score, and 5% and. 8% for the colon 
weight/body weight ratio, respectively). The activity of 
MPO was also decreased with the probiotic 
administration and the lowest value was observed when 
microparticulated probiotic was administered (Table 1). 
Macroscopic and histological evaluation confirmed the 
higher potential of the microencapsulated probiotic to 
decrease the parameters of inflammation (Figure 1). 
Visible segments of ulcerations were not observed in the 
fourth group, while at the histological sections 
subepithelial polymorph nuclear infiltration was observed 
with preserved epithelium. Also, in this group, dilated 
blood vessels in submucosal layer and dilated intestinal 
glands were observed (Figure 1d).  
     
    
Figure 1. Optical micrography of rats’ colons treated 
with a: PBS; b: TNBS in ethanol; c: non-encapsulated 
L. casei; b: microencapsulated L. casei. 
CONCLUSION 
In conclusion, the microparticluated L. casei showed high 
potential to be used as adjuvant therapy in IBD when 
incorporated in pharmaceutical dosage form or functional 
food product.  
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